Validations: Container/Closure Qualification & Seal Integrity

CCI Methods Selection: Vacuum Decay vs HVLD vs Mass-Spectrometry

CCI Methods Selection: Vacuum Decay vs HVLD vs Mass-Spectrometry In the pharmaceutical industry, ensuring the integrity of container closure systems (CCS) is vital for the quality and safety of drug products. The selection of appropriate analytical methods for container closure integrity (CCI) testing is crucial for compliance with regulatory expectations as articulated by the FDA, EMA, and other pertinent authorities….

Continue Reading CCI Methods Selection: Vacuum Decay vs HVLD vs Mass-Spectrometry

USP Sensitivity/DL Verification: Evidence That Satisfies Auditors

USP Sensitivity/DL Verification: Evidence That Satisfies Auditors USP Sensitivity/DL Verification: Evidence That Satisfies Auditors In the highly regulated pharmaceutical industry, the qualification of container closure systems and the assessment of extractables and leachables (E&L) is critical to ensuring product safety and compliance with regulatory requirements. This article provides a detailed, step-by-step guide focusing on the verification of sensitivity and detection…

Continue Reading USP Sensitivity/DL Verification: Evidence That Satisfies Auditors

Helium Leak Testing: Pros, Cons, and Matrix Effects

Helium Leak Testing: Pros, Cons, and Matrix Effects Introduction to Helium Leak Testing in Pharmaceutical Validation Pharmaceutical validation is a key aspect of ensuring product quality, efficacy, and safety in the production of drugs. One of the critical components of this process is the evaluation of container closure integrity (CCI), particularly for sterile products. Helium leak testing has emerged as…

Continue Reading Helium Leak Testing: Pros, Cons, and Matrix Effects

Method Transfers for CCI: Robustness and Routine Checks

Method Transfers for CCI: Robustness and Routine Checks Method Transfers for CCI: Robustness and Routine Checks Container closure integrity (CCI) is a critical aspect of pharmaceutical packaging systems, particularly for parenteral products. Ensuring the robustness of methods used to assess CCI is essential for regulatory compliance and patient safety. This guide outlines a comprehensive, step-by-step approach to method transfers for…

Continue Reading Method Transfers for CCI: Robustness and Routine Checks

Container/Closure Qualification Plan: From URS to PQ

Container/Closure Qualification Plan: From URS to PQ In the world of pharmaceutical manufacturing, ensuring the safety and efficacy of products is paramount. As such, the qualification of container closures and packaging systems, particularly with regard to extractables and leachables (E&L), must be approached with a thorough understanding of industry regulations and guidelines. This step-by-step tutorial guides pharmaceutical professionals through the…

Continue Reading Container/Closure Qualification Plan: From URS to PQ